Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure
- PMID: 21934132
- DOI: 10.1093/toxsci/kfr245
Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure
Abstract
The aim of this study was the development of an alternative testing method based on human embryonic stem cells for prenatal developmental toxicity with particular emphasis on early neural development. To this purpose, we designed an in vitro protocol based on the generation of neural rosettes, representing the in vitro counterpart of the developing neural plate and neural tube, and we challenged this complex cell model with retinoic acid (RA), a well-known teratogenic agent. The cells were exposed to different concentrations of RA during the process of rosettes formation. Morphological and molecular parameters were evaluated in treated as compared with untreated cells to detect both cytotoxicity and specific neural toxicity. Transcriptomic analysis was performed with microarray Affymetrix platform and validated by quantitative real-time PCR for genes relevant to early neural development such as HoxA1, HoxA3, HoxB1, HoxB4, FoxA2, FoxC1, Otx2, and Pax7. The results obtained demonstrated that neural rosette forming cells respond to RA with clear concentration-dependent morphological, and gene expression changes remarkably similar to those induced in vivo, in the developing neural tube, by RA exposure. This strict correspondence indicates that the neural rosette protocol described is capable of detecting specific teratogenic mechanisms causing perturbations of early neural development and therefore represents a promising alternative test for human prenatal developmental toxicity.
Similar articles
-
A comparison of gene expression responses in rat whole embryo culture and in vivo: time-dependent retinoic acid-induced teratogenic response.Toxicol Sci. 2012 Mar;126(1):242-54. doi: 10.1093/toxsci/kfr342. Epub 2012 Jan 18. Toxicol Sci. 2012. PMID: 22262565
-
Transcriptomic concentration-response evaluation of valproic acid, cyproconazole, and hexaconazole in the neural embryonic stem cell test (ESTn).Toxicol Sci. 2012 Feb;125(2):430-8. doi: 10.1093/toxsci/kfr293. Epub 2011 Nov 1. Toxicol Sci. 2012. PMID: 22045034
-
Time-response evaluation by transcriptomics of methylmercury effects on neural differentiation of murine embryonic stem cells.Toxicol Sci. 2011 Aug;122(2):437-47. doi: 10.1093/toxsci/kfr134. Epub 2011 May 25. Toxicol Sci. 2011. PMID: 21613230
-
Potency ranking of valproic acid analogues as to inhibition of cardiac differentiation of embryonic stem cells in comparison to their in vivo embryotoxicity.Reprod Toxicol. 2011 May;31(4):375-82. doi: 10.1016/j.reprotox.2010.11.012. Epub 2010 Nov 27. Reprod Toxicol. 2011. PMID: 21115111 Review.
-
Embryonic stem cell test: stem cell use in predicting developmental cardiotoxicity and osteotoxicity.Methods Mol Biol. 2012;889:147-79. doi: 10.1007/978-1-61779-867-2_10. Methods Mol Biol. 2012. PMID: 22669664 Review.
Cited by
-
EPITHELIAL REMODELING AND MICROBIAL DYSBIOSIS IN THE LOWER RESPIRATORY TRACT OF VITAMIN A-DEFICIENT MOUSE LUNGS.bioRxiv [Preprint]. 2024 Jun 22:2024.06.21.600110. doi: 10.1101/2024.06.21.600110. bioRxiv. 2024. PMID: 38948802 Free PMC article. Preprint.
-
A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors.Arch Toxicol. 2015 Sep;89(9):1599-618. doi: 10.1007/s00204-015-1573-y. Epub 2015 Aug 14. Arch Toxicol. 2015. PMID: 26272509 Free PMC article.
-
Prospects and Frontiers of Stem Cell Toxicology.Stem Cells Dev. 2017 Nov 1;26(21):1528-1539. doi: 10.1089/scd.2017.0150. Epub 2017 Oct 12. Stem Cells Dev. 2017. PMID: 28874109 Free PMC article. Review.
-
Emergence of undifferentiated colonies from mouse embryonic stem cells undergoing differentiation by retinoic acid treatment.In Vitro Cell Dev Biol Anim. 2016 May;52(5):616-24. doi: 10.1007/s11626-016-0013-5. Epub 2016 Apr 29. In Vitro Cell Dev Biol Anim. 2016. PMID: 27130680 Free PMC article.
-
iPSC Modeling of RBM20-Deficient DCM Identifies Upregulation of RBM20 as a Therapeutic Strategy.Cell Rep. 2020 Sep 8;32(10):108117. doi: 10.1016/j.celrep.2020.108117. Cell Rep. 2020. PMID: 32905764 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources